BREAKING NEWS
Covid-19 Drugs
Covid-19 Drugs
Source: Calcium Channel Inhibitors-SARS-CoV-2  Jan 20, 2022  8 days ago
Calcium Channel Inhibitors-SARS-CoV-2: A new study by researchers from the Institute of Biophysics, Johannes Kepler University Linz-Austria has found that calcium channel inhibitors including existing drugs such as amlodipine, nifedipine, felodipine, verapamil and the phytochemical neferine from the lotus plants can possibly treat SARS-CoV-2 infections. Strategies for inhibition of cellular ...
Source: SIRT5 Inhibitors As Potential COVID-19 Drugs  Jan 11, 2022  17 days ago
A new study by researchers from Buck Institute for Research on Aging-California, Gladstone Institute-California, University of California-San Francisco and the QBI COVID-19 Research Group (QCRG)-California has revealed that the SARS-CoV-2 coronavirus can be inhibited and controlled by downregulating human host SIRT5. The study findings showed that SIRT5 is a proviral factor and that SARS-CoV-2 lev...
Source: COVID-19 Drugs - Ramatroban  Jan 03, 2022  25 days ago
COVID-19 Drugs: A small clinical study conducted by researchers from the Charak Foundation-California-USA, Regulatory Wisdom-India, the EyeSight Eye Hospital and Retina Centre-India and the University of California Irvine-USA has found that the drug Ramatroban, which is a thromboxane A2 & prostaglandin D2 receptor antagonist can be used to treat COVID respiratory distress and hypoxem...
Source: COVID-19 Prophylactics-Therapeutics  Dec 14, 2021  2 months ago
COVID-19 Prophylactics-Therapeutics: Scientist from Friedrich-Alexander University Erlangen-Nürnberg-Germany, Ulm University Medical Center-Germany, University Hospital Tübingen-Germany and Marinomed Biotech AG-Austria have in a new study found that the safe and non-toxic natural compound iota-carrageenan has the ability to inhibit replication of all existing SARS-CoV-2 variants of ...
Source: COVID-19 Drugs - Calcium Channel Blockers   Dec 12, 2021  2 months ago
COVID-19 Drugs: A new study by researchers from Cornell University -New York has found that that entry of coronaviruses such as SARS-1, MERS and even SARS-CoV-2 is a Ca2+-dependent process. The study findings also propose that existing FDA approved calcium channel blockers could be repurposed as potential COVID-19 drugs. We are making a special appeal to all readers to please help to sustain this...
Source: COVID-19 Drugs   Dec 09, 2021  2 months ago
COVID-19 Drugs: A new study by scientists from the University of Florida-USA and the University of Saskatchewan has found that the common over-the-counter antihistamine diphenhydramine when paired with the commonly available supplement lactoferrin, a protein found in cow and human milk, the pair had the capability to hinder the SARS-CoV-2 virus during tests in monkey cells and ...
SourceL COVID-19 Drugs - Molnupiravir  Dec 05, 2021  2 months ago
COVID-19 Drugs: Updated data on molnupiravir shows the drug reduces hospitalization or death by 30%, down from the initially reported 50% efficacy. Last week Merck has provided updated data on its COVID-19 antiviral, molnupiravir, that shows the antiviral to be significantly less effective against the virus than previously thought. https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-p...
Source: COVID-19 Drug Scams-Favipiravir  Nov 29, 2021  2 months ago
Since the beginning of the pandemic, certain countries like China and Japan were advocating the use of Favipravir (Avigan) to treat COVID-19 despite lack of evidence to show its efficacy. Surprisingly, although China was advocating its use to other countries by giving and selling stocks of the drug, it was never really endorsed in its own national guidelines for COVID-19 treatment neither was it u...
Source: COVID-19 Prophylactics-Therapeutics  Nov 26, 2021  2 months ago
COVID-19 Prophylactics-Therapeutics: Researchers from the University of Tennessee Health Science Center-USA and Instituto de Ciencia y Tecnología-Argentina have in a new study demonstrated that a combination of iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture, paving the way for the development of a prophylactic and therapeutic nasal spray for COVID-19.   Since the...
Source: COVID-19 Drugs  Nov 16, 2021  2 months ago
COVID-19 Drugs: University of California-San Francisco and Stanford University researchers have in a new study involving the meta-analysis of health records from 87 health care centers across America found that individuals taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), especially Fluoxetine or Fluvoxamine were significantly less likely to die of COVID-19 ...
Source: Medical News-COVID-19 Drugs  Nov 14, 2021  2 months ago
COVID-19 Drugs: A new study by Austrian researchers from the Medical University of Vienna, Kaiser Franz Josef Hospital, University of Innsbruck and the Johannes Kepler University-Austria has found that not only does the anticoagulant-low molecular weight Heparin reduces the risk of disease severity and mortality about those with COVID019 but it also curtails the duration of the SARS-CoV-2 Infectio...
Source: COVID-19 Treatments - Hydrogen  Nov 13, 2021  3 months ago
COVID-19 Treatments: Researchers from Tianjin Medical University General Hospital-China and Weifang Medical University-China are exploring the usage of hydrogen therapy as a possible adjuvant treatment for COVID-19.   COVID-19 is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment to date except ...
Source: COVID-19 Drugs  Nov 09, 2021  3 months ago
COVID-19 Drugs: A new COVID-19 drug breakthrough study led by researchers from the Department of Infectious Diseases, Konkuk University-Gwangjin-gu-South Korea along with help from Chung-Ang University- Gyeonggi-South Korea has demonstrated that the pharmaceutical product called Hemin can be used to treat COVID-19 via heme oxygenase-1 Induction. The antiviral effects of heme oxygenase-1 (HO-1), a...
Source: SARS-CoV-2 Antivirals  Nov 08, 2021  3 months ago
SARS-CoV-2 Antivirals: Maybe as a result of an oversupply of Pacific oysters due to a trade spat with China, Australians are desperate to find alternative uses for their oysters or maybe there is some scientific basis after all since a study has been published in the peer reviewed journal: Reviews In Medical Virology, showing the possible benefits of hemoplymph from Pacific oysters (Crassostrea gi...
Source: COVID-19 Drugs  Oct 28, 2021  3 months ago
Fluvoxamine-COVID-19: The results from the TOGTHER clinical trial has shown that fluvoxamine reduces the risk of COVID-19 disease severity and reduces the need for hospitalization.   The TOGETHER trial is a randomized, adaptive platform trial to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. The trial was designed and done in partner...
Source: Autophagy-SARS-CoV-2  Oct 26, 2021  3 months ago
Autophagy-SARS-CoV-2: A review published by a researcher, Dr Theo Rein from the Max Planck Institute of Psychiatry, Munich-Germany in the peer reviewed Journal of Cellular Biochemistry highlights the importance of autophagy in the fight against SARS-CoV-2 infections and also identifies potential drugs that could be repurposed to treat COVID-19. https://onlinelibrary.wiley.com/doi/10.1002/jcb.30166...
Source: COVID-19 Drugs  Oct 25, 2021  3 months ago
COVID-19 Drugs: A new multinational research involving medical scientists from Aarhus University-Denmark, Istituto Pasteur Italia-Cenci Bolognetti Foundation-Italy, University of Ottawa-Canada and Ottawa Hospital Research Institute-Canada has found that the U.S, FDA approved antimicrobial drug Atovaquone has antiviral potential against the SARS-CoV-2 coronavirus and emerging VOCs and could be repu...
Source: Antithrombotics-COVID-19  Oct 21, 2021  3 months ago
Antithrombotics-COVID-19: A new multi-institutional clinical study has shown that antithrombotic therapy involving drugs like aspirin or apixaban is not warranted in COVID-19 outpatients. The researchers from Brigham and Women’s Hospital-Massachusetts, University of Pittsburgh-Pennsylvania, University of Illinois-Chicago, Intermountain Healthcare-Utah, National Heart, Lung, and Blood Instit...
Source: COVId-19 Drugs  Oct 20, 2021  3 months ago
COVID-19 Drugs: A new multinational retrospective cohort study by researchers from Penn State College of Medicine, Pennsylvania-USA shows that glucose-regulating medications used to treat obesity and type-2 diabetes may improve outcomes in COVID-19 patients with type-2 diabetes. It has already been known that individuals with type 2 diabetes mellitus (T2DM) are at increased risk of severe COVID-1...
Source: COVID-19 Drugs  Oct 15, 2021  4 months ago
COVID-19 Drugs: A new study that analyzes real-world data utilizing artificial intelligence by researchers from AdventHealth Research Institute-Orlando, Oak Ridge National Laboratory-Tennessee and the University of Tennessee has found that the antiemetic drug Zofran (Ondansetron) lowers risk of mortality of severe COVID-19 patients on ventilators and is associated with increased survival of these ...
Source: Monoclonal Antibodies-SARS-CoV-2 Variants  Oct 07, 2021  4 months ago
Monoclonal Antibodies-SARS-CoV-2 Variants: If anything, the COVID-19 pandemic has revealed to those intelligent enough to understand anything that the elites in the United States are nothing more than the most filthy, unethical and greedy and corrupted live forms ever to emerge this earth.   From day one of the pandemic, certain American elites have been controlling the narratives of the COV...
Source: COVID-19 Exposé   Sep 24, 2021  4 months ago
COVID-19 Exposé : First it was the Trump Administration along with the U.S.NIH or to be specific the NIAID headed by Anthony Fauci that poured millions of dollars in to the development and research of the overpriced drug remdesivir that is not only hepatoxic but also nephrotoxic to treat COVID-19. There are tons of studies that confirm its toxicity issues, these are just a few.   http...
Source: COVID-19-Drugs  Sep 22, 2021  4 months ago
COVID-19 Drugs: A researcher from the University of Lahore Pakistan has proposed that the drug aprepitant could be used to target the neurokinin-1 receptors to prevent COVID-19 cytokine storms.   Aprepitant is a medication used in the management and treatment of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV). It is in the neurokinin-1 a...
Source: COVID-19 Drugs  Sep 16, 2021  4 months ago
COVID-19 Drugs: The phase 1a clinical trial led by researchers from the University of Liverpool-UK using the antiparasitic drug Nitazoxanide has shown potential in terms of treating the COVID-19 disease. The research team also comprised clinicians and scientist from University of Southampton-UK, University of Cambridge-UK, the Liverpool School of Tropical Medicine-UK and the Liverpool University H...
Source: COVID-19 Drugs-Fluvoxamine  Sep 06, 2021  5 months ago
COVID-19 Drugs: Results from the TOGETHER multi-institutional, multi-country randomized platform clinical trials of various repurposed drugs to treat COVID-19 has shown that  treatment with fluvoxamine (100mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19, reduced the need for extended emergency room observation or hospitalization.   The institutions ...
Source: COVID-19 Drugs  Sep 04, 2021  5 months ago
COVID-19 Drugs: Researchers from the University of California-San Francisco along with support from Stanford University are exploring the use of the abortion drug Ethacridine to inhibit SARS-CoV-2 by inactivating viral particles and to assess its potential as a prophylaxis and also therapeutic agent to treat COVId-19. Their study findings were published in the peer reviewed journal: PLOS Pathogen...
Source: Pulmonary Fibrosis  Sep 01, 2021  5 months ago
A new breakthrough study by researchers from University of Alabama at Birmingham-USA has found that the drug Venetoclax used to treat adult patients with Chronic Lymphocytic Leukemia (CLL) could be repurposed to reverse lung fibrosis after successful mouse model drug trials. Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymp...
Source: COVID-19 Drugs  Sep 01, 2021  5 months ago
Researchers from the Centro Nacional de Investigaciones Cardiovasculares (CNIC)-Spain and the IIS-Fundación Jiménez Díaz University Hospital-Spain have in a new clinical study discovered that metprolol- a cheap drug widely used to treat cardiovascular disease, is beneficial in treating severely ill COVID-19 patients.   Metoprolol, sold under the brand name Lopressor, amo...
Source: COVID-19 Drugs  Aug 21, 2021  5 months ago
COVID-19 Drugs: A detailed meta-analytical study by researchers from the University of Virginia-USA, Humboldt-Universität zu Berlin-Germany,  Freie Universität-Germany and  Berlin Institute of Health, of previous research findings including clinical trials has revealed that the heartburn drug famotidine used alongside Aspirin has the potential to prevent disease severity a...
Source: COVID-19 Drugs-Fluvoxamine  Aug 14, 2021  6 months ago
COVID-19 Drugs: Fluvoxamine, an inexpensive anti-depressant drug is now emerging as a potential candidate to be repurposed to treat COVID-19. Speculations are adrift that Canada might be the first country to approve its usage to treat COVID-19 followed by the United States, India, Brazil and South Africa.   Fluvoxamine, sold under the brand name Luvox among others, is an antid...
Source: COVID-19 Drugs  Aug 13, 2021  6 months ago
Despite so many small randomized clinical trials and observational studies that showed Ivermectin could be used to treat COVID-19 during the early stages of the COVID-19 pandemic, physicians, researchers and individuals should stop attempting to treat COVID-19 with Ivermectin as the drug as no efficacy against most of the new variants that are currently dominating various countries. Thailand Medi...
Source: COVID-19 Therapeutics  Aug 09, 2021  6 months ago
COVID-19 Therapeutics: A new research led by scientists from Yale University along with other experts from University of Minnesota and Iowa State University has found that a crucial enzyme known as the Coronavirus 3′–5′ exoribonuclease (ExoN) promotes antiviral resistance hence making many identified drugs such as remdesivir, ivermectin and even identified antiviral phytochemical...
Source: COVID-19 Drugs  Aug 07, 2021  6 months ago
COVID-19 Drugs: A new mouse based vivo study by researchers from the Scripps Research Institute-California along with scientist from the University of Texas and Sorrento Therapeutics Inc.-California have found that salicylanilides which are active pharmaceutical ingredients (APIs) found in drugs used to treat tapeworm infestations demonstrated efficacy in terms of inhibiting the SARS-CoV-2 coronav...
Source: COVID-19 Drugs  Aug 07, 2021  6 months ago
COVID-19 Drugs: Scientists from the University of Birmingham and Keele University in the UK and the San Raffaele Scientific Institute in Italy have demonstrated that the licensed cholesterol lowering drug fenofibrate and its active form (fenofibric acid) can significantly reduce SARS-COV-2 infection in human cells in the laboratory. Importantly, reduction of infection was obtained using conce...
Source: COVID-19 Drugs  Aug 04, 2021  6 months ago
COVID-19 Drugs: A new in vitro study conducted by researchers from University of Georgia-US and Shahid Beheshti University-Iran has found that the common high pressure drug called Losartan is able to inhibit SARS-CoV-2 coronavirus replication.   Losartan, sold under the trade name Cozaar among others, is a medication mainly used to treat high blood pressure. Losartan belongs to a gr...
Source: miRNAs and SARS-CoV-2  Aug 02, 2021  6 months ago
COVID-19 Therapeutics: Researchers from Gujarat University inspired by Thailand Medical News call to focus on Phytochemicals and microRNAs as solutions to containing the SARS-CoV-2 pandemic have in a new study utilizing computational workflow, identified potential cellular miRNA candidates that are potent in providing antiviral defense against SARS-CoV-2 infection. The study team designed a syste...
Source: COVID-19 Drugs-Budesonide  Jul 29, 2021  6 months ago
Another study finding has emerged proving the antiviral effects of Budesonide when used either as an inhaler or as a nasal spray.   German researchers from the Ruhr-University Bochum and also from the European Virus Bioinformatics Center (EVBC) based in Jena-Germany have in a new study confirmed the viral effects of Budesonide against the wildtype SARS-CoV-2 coronavirus and even against the ...
Source: COVID-19 Antivirals  Jul 29, 2021  6 months ago
A new study by scientists from the National Institutes for Food and Drug Control (NIFDC)-China has found that lectins derived from lentils (Lens culinaris)- a staple in Indian cuisine often known as dhal, exhibits antiviral properties against the SARS-CoV-2 coronavirus. The study findings were published in the peer reviewed journal: Emerging Microbes and Infection. https://www.tandfonline.com/doi...
Source: Breaking COVID-19 News  Jul 28, 2021  6 months ago
A new study by researchers from the University of Reading, Reading, United Kingdom has found that inflammation and blood clotting seen in very severe cases of COVID-19 may be caused by the antibodies sent to fight the disease activating unnecessary platelet activity in the lungs. According to the study team a subset of patients with COVID-19 typically become critically ill, suffering from severe ...
Source: Herbs and Phytochemicals for COVID-19.  Jul 24, 2021  6 months ago
As the COVID-19 pandemic fast accelerates into a more catastrophic mode and there are still no effective antivirals to date plus antibody therapies as well as vaccines are beginning to show signs of being defeated by the new emerging variants, there is a dire need for effective therapeutics against the SARS-CoV-2 coronavirus and various study teams around the world are frantically searching for pr...
Source: Epstein-Barr virus and COVID-19  Jul 22, 2021  6 months ago
A number of studies are emerging that indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases. It has been found that Coronavirus disease 2019 (COVID-19) patients sometimes experience long-term symptoms following resolution of acute disease, including fatigue, brain fog, and rashes.   One study published ...
Source: COVID-19 Drugs  Jul 19, 2021  6 months ago
A new study by biotech researchers from Hangzhou-China involved in a development of new drug formulation has found that N-Acetylneuraminic Acid (NANA)  and its analogs such as acetylneuraminic acid methyl ester (NANA-Me) are able prevent and also treat adverse reactions caused by COVID-19 infections and also by COVID-19 vaccines. Edible Bird's Nest- A Good Source Of N-Acetylneuramin...
Source: COVID-19 Drugs-Statins  Jul 16, 2021  7 months ago
COVID-19 Drugs: A new study by researchers from the University of California-San Diego School Of medicine-USA has confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19. According to the study team, statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of the COVID-19 disease, in which organ dysfunction i...
Source: COVID-19 Therapeutics  Jul 15, 2021  7 months ago
COVID-19 Therapeutics: A new study by researchers from University of Fukui-Japan shows that Short Chain Fatty Acids (SCFAs) could be used as potential therapeutics to treat COVID-19 and also to act as a prophylaxis. The researchers showed that SCFAs could downregulate ACE2 in epithelial cells. According to the study team inflammatory endotype affects ACE2 expression in the nasal mucosa and influe...
Source: COVID-19 Clinical Care-Heparin  Jul 14, 2021  7 months ago
COVID-19 Clinical Care: A new study undertaken by medical researchers from the St. Michael's Hospital, a treatment site of Unity Health Toronto and the University of Vermont Larner College of Medicine indicates that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of...
Source: COVID-19 Drugs-Aspirin  Jul 14, 2021  7 months ago
Aspirin-COVID-19: A detailed systematic review and meta-analysis study by researchers from the Michigan State University, USA has found that aspirin usage is associated with a significant reduction in overall and in-hospital mortality rates. The current COVID-19 pandemic has so far caused more than 4.05 million deaths and far more are expected to die in coming surges.   The benefits of aspir...
Source: Coronavirus News  Jul 03, 2021  7 months ago
Coronavirus News: A new study by researcher from Université Paul Sabatier-France, Ecole Nationale Vétérinaire d’Alfort-France,  Université Grenoble Alpes-France and also involving scientist from Ghent University-Belgium has shown that mannose-specific lectins derived from plants, algae, fungi, and bacteria selectively bind N-glycans present on the surface of ...
Source: COVID-19 Drugs  Jul 03, 2021  7 months ago
COVID-19 Drugs: A new study by American and Swiss researchers from University of Pennsylvania , University of Maryland, National Institutes of Health-USA and Epithelix-Switzerland demonstrates that usage of pyrimidine biosynthesis inhibitors such as Mycophenolate, Azathioprine And Leflunomide in conjunction with nucleoside analogs (Examples of such nucleoside analogs  include Remdesivir and M...
Source: COVID-19 Drugs And Supplements  Jul 01, 2021  7 months ago
COVID-19 Treatments: A new study by researchers from the Royal Institute of Technology-Sweden, University of Health Sciences-Turkey, Istanbul Technical University-Turkey, Atatürk University-Turkey, Chalmers University of Technology-Sweden, University of Gothenburg and Sahlgrenska University Hospital-Sweden and Istanbul Medipol University-Turkey has found that metabolic activators such as nico...
Source: COVID-19 Drugs  Jun 30, 2021  7 months ago
Remdesivir the controversial drug that was deemed to be ineffective in WHO’S SolidarityTrial (https://www.thailandmedical.news/news/latest-who-s-solidarity-drug-trial-shows-that-remdesivir-is-not-the-least-effective-in-treating-covid-19) but is still being approved as a drug to treat COVID-19 under EUA status in the United States by the no longer credible US FDA is now facing more backlash a...
Source: COVID-19 Drugs  May 31, 2021  8 months ago
COVID-19 Drugs: Canadian researchers from the Montreal Heart Institute (MHI) and the Université de Montréal announced the clinical trial findings of the COLCORONA study (NCT04322682), which was  a phase 3, randomized, double-blind, adaptive, placebo-controlled, multicentre trial of the oral anti-inflammatory medication called Colchicine on hospitalized COVID-19 patients. The stu...
Source: COVID-19 Drugs  May 08, 2021  9 months ago
COVID-19 Drugs: About 3 hours ago, the Indian drug regulatory body, DCGI has granted emergency approval for the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr Reddy’s Laboratories, Hyderabad, as an adjuvant drug to treat hospitalized COVID-19 patients and also to reduce supplemental oxygen dependence. &n...
Source: COVID-19 Drugs  May 06, 2021  9 months ago
COVID-19 Drugs:  A new research by researchers from Japan shows that the teratogenic drug: Favipiravir that certain ignorant countries are using to treat COVID-19 can also induced liver injury if the serum concentration of the drug exceeds a certain threshold!   The study findings were published on a preprint server and are currently being peer reviewed by teams from the United States ...
Source: Aspirin-COVID-19  Mar 21, 2021  10 months ago
A new study led by researchers from George Washington University and also included scientists from the University of Maryland, Wake Forest School of Medicine, Northeast Georgia Health System, Walter Reed National Military Medical Center, University of California-San Francisco and the University of Oklahoma School of Medicine have found that low dose aspirin may reduce the need for mechanical venti...
Source: COVID-19 Antivirals  Feb 04, 2021  12 months ago
COVID-19 Antivirals: Japanese researchers from National Institute of Infectious Diseases, Tokyo and the Tokyo University of Science have in a new study found that oxidized cholesterol derivatives or oxysterol exhibits potent antiviral activity against the SARS-Cov-2 coronavirus.   Developments of effective antiviral drugs targeting SARS-CoV-2 are urgently needed to combat the COVID-19 disea...

MOST READ

Feb 05, 2020  2 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  2 years ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  2 years ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  2 years ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  2 years ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  2 years ago
Source: Myocardial Injury
Jun 09, 2020  2 years ago
Source: COVID-19 News
May 21, 2020  2 years ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  2 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  2 years ago
Source : Thailand Medical News
Feb 11, 2020  2 years ago